Sitemap - 2026 - The Active Surveillor

AnCan going European with its unique brand of support

Special sports edition. Shrouds of AS Silence: Star athletes open about PCa treatment, but secretive about Active Surveillance?

Good news for AS from a couple of big names in health care: Diet and lifestyle can slow or even halt low-risk prostate cancer and more

German researchers find a single baseline PSA in midlife may help men safely avoid years of repeat testing and invasive procedures

Denial Isn’t Just a River in Egypt: Have You Faced Insurance Discrimination for Gleason 6 or 7 (Grade Group 1–2)? Let me know about it.

No Battles. No Wars. No Journeys. No Heroes. No Survivors. No more B.S.: How We Talk About Low-Risk PCa And Other Diseases

Overtreatment largely old news, but remains an issue in older men with higher risk cancers, U of Michigan researcher

'We don’t want to find patients for Active Surveillance. We want to find patients who need treatment.'--Dr. Jason Hafron

Get your 2nd opinions--including for Gleason 6--from an expert uropathologist you trust, says Dr. Jonathan Epstein

Still time to register to see top uropathologist Jonathan Epstein this Saturday, Jan. 24

Hopscotching the headlines: how I beat a kidney stone, webinar with Dr. Epstein, an essay in STAT News and nominations for ASPI awards

Understanding Your Prostate Biopsy Report with Dr. Jonathan Epstein--He's coming a bit earlier on Saturday

The Great Prostate Cancer Active Surveillance Illusion: Uroheretics Vorstman and Piana back with a critical view of Active Surveillance

Why Dr. Geo 'loves' Active Surveillance

Is it safe? Gadolinium finding its way into our drinking water, oceans, even soft drinks

Active Surveillance '26 webinar now available on YouTube for paid subscribers

Slimming down the tumor’s 'fuel': Can weight-loss 'jabs'--soon-to-be GLP-1 pills--impact prostate cancer? Maybe.

The Class of 2025: Prostate cancer diagnoses and deaths in high-profile people

Issue of overtreatment largely old news, but remains an issue in older men with higher risk cancers, U of Michigan researcher